Experience

Our commercially savvy lawyers regularly lead strategic transactions and complex disputes for clients in a variety of industries and regions. We’ve included a small selection of matters for your convenience.
Practice
Industry
Region

The Special Committee of the Board of Directors of Yandex in a restructuring of its corporate governance.

Debevoise & Plimpton LLP has advised the Special Committee of the Board of Directors of Nasdaq-listed Yandex N.V. (“Yandex”), one of Europe's largest internet companies and a leading tech business in Russia, on a complex and novel restructuring of its corporate governance. Read More>

The Carlyle Group in its $1.8 billion acquisition, with T&D Holdings, of a majority interest in Fortitude Re.

Debevoise & Plimpton LLP is advising The Carlyle Group in its partnership with T&D Holdings to acquire from AIG a 76.6 percent ownership interest in Fortitude Group Holdings, whose group companies operate as Fortitude Re, for approximately $1.8 billion. After closing, ownership interests in Fortitude Re will include Carlyle and its fund investors at 71.5 percent (including the 19.9 percent stake previously acquired by Carlyle in November 2018), T&D at 25 percent and AIG at 3.5 percent. For more information, please see The Carlyle Group’s release. Read More>

J.P. Morgan Securities, as financial advisor to The Medicines Co., in its $9.7 billion acquisition by Novartis AG.

Debevoise & Plimpton LLP is advising JP Morgan Securities Inc. as financial advisor to The Medicines Co. (NASDAQ: MDCO) in its $9.7 billion acquisition by Novartis AG (NASDAQ: NVS), expanding Novartis’ portfolio to include the maker of inclisiran, a drug candidate that lowers cholesterol and showed promise in recent Phase III trials. The two companies will continue to operate independently until the deal has been completed. The transaction is expected to close in the first quarter of 2020. For more information, read The Medicines Company’s press release. Read More>

Clayton, Dubilier & Rice in its $205 million acquisition of Cynosure from Hologic.

Debevoise & Plimpton LLP is advising Clayton, Dubilier & Rice (“CD&R”), a private investment firm, in its acquisition of Cynosure, LLC, a market-leading medical aesthetics technology company. Under the terms of the agreement, approximately 825 employees will transfer with the Cynosure business.  The transaction is expected to close in January 2020, subject to regulatory approvals and other customary conditions. UBS has committed to provide debt financing as part of the transaction and is acting as financial advisor to CD&R. This carveout style transaction positions Cynosure for accelerated growth under new ownership and is expected to have an immaterial impact on Hologic Inc.’s (Cynosure’s parent company) revenue growth rate, while increasing non-GAAP gross and operating margin as a percentage of revenue. For more information, please see CD&R’s release. Read More>

Emergent Cold Storage, an Elliott Management portfolio company, in its sale to Lineage Logistics.

Debevoise & Plimpton LLP is advising Emergent Cold Storage, a portfolio company of Elliott Management Corporation, in its sale to Lineage Logistics, LLC. The deal is expected to close in 2020. Read the company press release here. Read More>